[Therapy of orthostatic hypotension].
Oldenburg
O
O
Abteilung für Kardiologie, Universitätsklinikum Essen. olaf.oldenburg@uni-essen.de
Sack
S
S
Erbel
R
R
Philipp
T
T
Kribben
A
A
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D004087:Dihydroergotamine / Q000627:therapeutic use; D005438:Fludrocortisone / Q000627:therapeutic use; D006801:Humans; D007024:Hypotension, Orthostatic / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D008790:Metoprolol / Q000627:therapeutic use; D008901:Mineralocorticoids / Q000627:therapeutic use; D005996:Nitroglycerin / Q000627:therapeutic use; D010138:Pacemaker, Artificial; D011187:Posture; D012076:Renal Agents / Q000627:therapeutic use; D012890:Sleep; D013566:Sympathomimetics / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D016861:Cyclooxygenase Inhibitors; D008901:Mineralocorticoids; D012076:Renal Agents; D013566:Sympathomimetics; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D004087:Dihydroergotamine; D003894:Deamino Arginine Vasopressin; D005996:Nitroglycerin; D008790:Metoprolol; D005438:Fludrocortisone